Press Resease

Prosthetic Heart Valve Market - Global Industry Analysis

Prosthetic Heart Valve Market by Type (Transcather, Tissue and Mechanical): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Published Date: 13-Oct-2016 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-234 Status : Published

Global demand for prosthetic heart valve market expected to reach USD 5,302.1 million in 2021 and growing at a CAGR of 9.10% from 2016 to 2021.

Description

The prosthetic heart valve market report covers forecast and analysis on a global and regional level. The study provides historic data 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study comprises of drivers and restraints for the market along with their impacts on demand over the forecast period. In addition, the prosthetic heart valve market report provides detail study of opportunities existing in prosthetic heart valve market on a global level. 

The competitive scenario and product portfolio of the key manufacturers are included in the report, in order to provide the users of this report with the comprehensive view of the prosthetic heart valve market. The competitive landscape in the prosthetic heart valve market is well explained with an analysis of Porter’s five forces model, strategic development, and patent analysis. The study cover in market attractiveness analysis, in which type segments are benchmarked based on their market size, growth rate, and attractiveness. 

There are mainly three types of the prosthetic heart valve that are transcatheter valves, tissue valve, and the mechanical valve. All the segments have been analyzed based on current and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil.

The report provides the comprehensive competitive view with company profiles of the key players operating in the global market. Key players profiled in the report include Colibri Heart Valve, LLC, Cytograft Tissue Engineering, Inc. (CTE), Direct Flow Medical, Inc., Edwards Lifesciences LLC, Heart Leaflet Technologies (HLT), Perouse Medical, St. Jude Medical Inc., and Sorin Group. 

This report segments the prosthetic heart valve market as follows:

Prosthetic Heart Valve Market: Type Segment Analysis

  • Transcatheter valve 
  • Tissue valve
  • Mechanical valve

Prosthetic Heart Valve Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany 
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2015 - 2021(USD Million)
    • 2.2. Global prosthetic heart valve market: Snapshot
  • Chapter 3. Prosthetic Heart Valve Market – Global and Industry Analysis
    • 3.1. Prosthetic heart valve: Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global prosthetic heart valve market: Impact analysis
      • 3.2.2. Increasing prevalence of heart disorders
    • 3.3. Market restraints
      • 3.3.1. Restraints of global prosthetic heart valve market: Impact analysis
      • 3.3.2. High cost of the therapy
    • 3.4. Opportunities
      • 3.4.1. Increasing demand from the emerging economies
      • 3.4.2. Introduction of new techniques
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by type segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Prosthetic Heart Valve Market - Competitive Landscape
    • 4.1. Company market share, 2014
      • 4.1.1. Global prosthetic heart valve market : company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Product Portfolio
    • 4.4. Patent Analysis (2011-2016)
      • 4.4.1. Patent Trend
      • 4.4.2. Patent Share by company
      • 4.4.3. By Region
  • Chapter 5. Global Prosthetic Heart Valve Market – Type Segment Analysis
      • 5.1. Global prosthetic heart valve market: type overview
    • 5.1.1. Global prosthetic heart valve market revenue share, by type, 2015 - 2021
    • 5.2. Transcather valve
      • 5.2.1. Global prosthetic heart valve market, by transcather valve, 2015 - 2021(USD Million)
    • 5.3. Tissue valve
      • 5.3.1. Global prosthetic heart valve market, by tissue valve, 2015 - 2021(USD Million)
    • 5.4. Mechanical valve
      • 5.4.1. Global prosthetic heart valve market, by mechanical valve, 2015 - 2021(USD Million)
  • Chapter 6. Global Prosthetic Heart Valve market – Regional Segment Analysis
    • 6.1. Global prosthetic heart valve market: Regional overview
      • 6.1.1. Global prosthetic heart valve market revenue share by region, 2015 - 2021
    • 6.2. North America
      • 6.2.1. North America prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
    • 6.3. Europe
      • 6.3.1. Europe prosthetic heart valve market revenue, by a type, 2015 - 2021(USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.3.3. France
        • 6.3.3.1. France prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.3.4. UK
        • 6.3.4.1. UK prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.4.2. China
        • 6.4.2.1. China prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.4.4. India
        • 6.4.4.1. India prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
    • 6.6. Middle East and Africa
      • 6.6.1. Middle East and Africa prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
  • Chapter 7. Company Profile
    • 7.1. Colibri Heart Valve, LLC
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Cytograft Tissue Engineering, Inc. (CTE)
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Direct Flow Medical, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Edwards Lifesciences LLC
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Heart Leaflet Technologies (HLT)
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Perouse Medical
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. St. Jude Medical Inc.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. Sorin Group
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Symetis
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments
    • 7.10. Transcatheter Technologies Gmbh
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product portfolio
      • 7.10.4. Business strategy
      • 7.10.5. Recent developments
    • 7.11. On-X Life Technologies, Inc.
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product portfolio
      • 7.11.4. Business strategy
      • 7.11.5. Recent developments
    • 7.12. Neovasc Inc.
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product portfolio
      • 7.12.4. Business strategy
      • 7.12.5. Recent developments
    • 7.13. Micro Interventional Devices, Inc
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product portfolio
      • 7.13.4. Business strategy
      • 7.13.5. Recent developments
    • 7.14. Leman Cardiovascular
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product portfolio
      • 7.14.4. Business strategy
      • 7.14.5. Recent developments
    • 7.15. JenaValve Technology
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product portfolio
      • 7.15.4. Business strategy
      • 7.15.5. Recent developments
    • 7.16. Boston Scientific Corporation
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product portfolio
      • 7.16.4. Business strategy
      • 7.16.5. Recent developments
    • 7.17. Claret Medical, Inc.
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product portfolio
      • 7.17.4. Business strategy
      • 7.17.5. Recent developments
    • 7.18. Medtronic, Inc.
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product portfolio
      • 7.18.4. Business strategy
      • 7.18.5. Recent developments
    • 7.19. TTK Healthcare
      • 7.19.1. Overview
      • 7.19.2. Financials
      • 7.19.3. Product portfolio
      • 7.19.4. Business strategy
      • 7.19.5. Recent developments
    • 7.20. Braile Biomédica
      • 7.20.1. Overview
      • 7.20.2. Financials
      • 7.20.3. Product portfolio
      • 7.20.4. Business strategy
      • 7.20.5. Recent developments
  • Chapter 8. Patents
    • 8.1. U.S. (US Patents)
    • 8.2. Europe (EP documents)
    • 8.3. Japan (Abstracts of Japan)
    • 8.4. Global (WIPO (PCT))

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Prosthetic Heart Valve market. Zion Research has collected and analyzed key data belong to the global Prosthetic Heart Valve market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Prosthetic Heart Valve across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Prosthetic Heart Valve industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Prosthetic Heart Valve market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Prosthetic heart valve therapy is carried out for the patients suffering from the valvular heart disorder. Heart valve replacement was carried out in the early 1960s. It is reported that more than 60,000 patients undergo replacement surgery in U.S. every year and around 280,000 heart valve replacement cases worldwide. Prosthetic heart valve has 3 major types that are mechanical heart valve, tissue heart valve and transcatheter heart valve which is recently developed technique. Growing R&D for innovated techniques and introduction of new valves and valve replacement therapies foster the growth of prosthetic heart valve market. 

The prosthetic heart valve market is primarily driven by factors such as rapid advancement in technology, rising occurrence of heart disorders and growth in aging population. Moreover, surging healthcare expenditure along with rising focus of major players on R&D for innovative products fuels the growth of the market. In addition, increasing awareness of heart valve replacement and availability of techniques for valve replacement stimulates the growth of the market. However, stringent regulations led by government mainly for use of tissue heart valve and the high cost of the surgery may impede the growth of prosthetic heart valve market. Nevertheless, the introduction of advance and minimally invasive techniques with high efficiency is likely to offer the ample opportunities for this market in the forecast period.

Global Prosthetic Heart Valves Market

There are mainly three types of a prosthetic heart valve that are transcatheter valves, tissue valve, and the mechanical valve. Tissue valve was considered to be the most prominent segment and gathered the highest share in 2015. Tissue valve is extracted from the pig and cow and treated for preventing rejection from the human body. Transcatheter heart valve is utilized to replace the damaged valve in the transcatheter aortic valve replacement (TAVR). In the TAVR, the damaged valve is repaired instead of replacing and is done with minimal invasion. 

North America dominated the prosthetic heart valve market with the highest share in 2015. It is expected that the market in North America will gain traction in the forecast period owing to rising prevalence of heart valve disorders and increasing preference for minimal invasive practices. Moreover, surging demand for tissue heart valve replacement in U.S. will fuel the growth of the market in North America. Asia-Pacific is the fastest growing market for prosthetic heart valve due to rising disposable income along with escalating demand for valve replacement, particularly in India and China. Latin America is anticipated to experience sustainable growth in the coming years owing to unexploited market. The Middle East and Africa is estimated to grow at the moderate pace due to growing awareness and developing technologies.

Competition in the prosthetic heart valves market is intense and to stay competitive, companies are adopting strategies such as product innovation and inorganic growth. Some of the key players in the prosthetic heart valve market are Colibri Heart Valve, LLC, Cytograft Tissue Engineering, Inc. (CTE), Direct Flow Medical, Inc., Edwards Lifesciences LLC, Heart Leaflet Technologies (HLT), Perouse Medical, St. Jude Medical Inc.,and Sorin Group.

Other prominent participants in the market include Symetis, Transcatheter Technologies Gmbh, On-X Life Technologies, Inc., Neovasc Inc., Micro Interventional Devices, Inc, Leman Cardiovascular, JenaValve Technology, Boston Scientific Corporation, Claret Medical, Inc., Medtronic, Inc., TTK Healthcare and Braile Biomédica among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social